PPARGC1A and metabolic dysfunction-associated steatotic liver disease: One additional study18 found that PPARGC1A methylation status was significantly associated with NAFLD, and 47.9% of alleles were methylated in participants with NAFLD vs 30.6% in healthy controls (P < .01).